Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Poly[[bis-[?(2)-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]manganese(II)] dihydrate].

ABSTRACT: In the title compound, {[Mn(C(14)H(16)N(5)O(3))(2)]·2H(2)O}(n), the Mn(II) atom (site symmetry ) exhibits a distorted trans-MnN(2)O(4) octa-hedral geometry defined by two monodentate N-bonded and two bidentate O,O'-bonded 8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ate anions. An N-H?O hydrogen bond is present in the crystal structure. The extended two-dimensional structure is a square grid and the disordered uncoordinated water mol-ecules occupy cavities within the grid.

SUBMITTER: Huang J

PROVIDER: S-EPMC2961022 | biostudies-other | 2008

REPOSITORIES: biostudies-other

ACCESS DATA

Json Xml

Publications

Poly[[bis-[μ(2)-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]manganese(II)] dihydrate].

Huang Jing J Hu Wei-Ping WP An Zhe Z

Acta crystallographica. Section E, Structure reports online 20080314 Pt 4

In the title compound, {[Mn(C(14)H(16)N(5)O(3))(2)]·2H(2)O}(n), the Mn(II) atom (site symmetry ) exhibits a distorted trans-MnN(2)O(4) octa-hedral geometry defined by two monodentate N-bonded and two bidentate O,O'-bonded 8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ate anions. An N-H⋯O hydrogen bond is present in the crystal structure. The extended two-dimensional structure is a square grid and the disordered uncoordinated water mol-ecules occupy cavities with ...[more]

PMID: 21202004

Similar Datasets

Poly[[bis-[?(2)-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]zinc(II)] dihydrate].

Project description:The title compound, {[Zn(C(14)H(16)N(5)O(3))(2)]·2H(2)O}(n) or [Zn(ppa)(2)]·2H(2)O}(n), where ppa = 8-ethyl-5,8-dihydro-5-oxo-2-(1-piperazin-yl)-pyrido(2,3-d)-pyrimidine-6-carboxyl-ate, was synthesized under hydro-thermal conditions. The Zn(II) atom (site symmetry ) exhibits a distorted trans-ZnN(2)O(4) octa-hedral geometry defined by two monodentate N-bonded and two bidentate O,O-bonded ppa monoanions. The extended two-dimensional structure arising from this connectivity is a square grid and the disordered uncoordinated water mol-ecules occupy cavities within the grid. An N-H?O hydrogen bond occurs.

| S-EPMC2970219 | biostudies-literature

Poly[[bis-[?(2)-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]cobalt(II)] dihydrate].

Project description:The title compound, {[Co(C(14)H(16)N(5)O(3))(2)]·2H(2)O}(n) or [Co(ppa)(2)]·2H(2)O}(n), where ppa denotes the 8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carb-ox-yl-ate anion, was synthesized under hydro-thermal conditions. The Co(II) atom (site symmetry ) exhibits a distorted trans-CoN(2)O(4) octa-hedral geometry defined by two monodentate N-bonded and two bidentate O,O'-bonded ppa anions. The extended two-dimensional structure is a square grid, which is consolidated by N-H?O hydrogen bonds. The disordered uncoordinated water mol-ecules occupy cavities within the grid.

| S-EPMC2971434 | biostudies-literature

Poly[bis-[8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]cadmium].

Project description:The title layered coordination polymer, [Cd(C(14)H(16)N(5)O(3))(2)](n) or [Cd(ppa)(2)](n), where ppa is 8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ate, was syn-thesized under hydro-thermal conditions. The Cd(II) atom (site symmetry 2) exhibits a distorted cis-CdN(2)O(4) octa-hedral geometry defined by two N-monodentate and two O,O'-bidentate ppa monoanions. The extended two-dimensional structure resulting from the bridging ppa species is a grid lying parallel to (001). An N-H?O hydrogen bond helps to establish the crystal packing.

| S-EPMC3009211 | biostudies-literature

Poly[bis-[?(2)-8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]nickel(II)].

Project description:The title compound, [Ni(C(14)H(16)N(5)O(3))(2)](n) or [Ni(ppa)(2)](n), where ppa is 8-ethyl-5-oxo-2-(piperazin-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ate, was synthesized under hydro-thermal conditions. The Ni(II) atom (site symmetry ) exhibits a distorted trans-NiN(2)O(4) octa-hedral geometry defined by two monodentate N-bonded and two bidentate O,O'-bonded ppa monoanions. The extended two-dimensional structure is a square grid. An inter-molecular N-H?O hydrogen bond occurs.

| S-EPMC2979888 | biostudies-other

Diaqua-bis-[8-ethyl-5-oxo-2-(piperazin-4-ium-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato]copper(II) bis[4-(4-carboxyphenoxy)benzoate].

Project description:In the title compound, [Cu(C(14)H(17)N(5)O(3))(2)(H(2)O)(2)](C(14)H(9)O(5))(2), the Cu(2+) atom, located on an inversion centre, exhibits a distorted octa-hedral geometry, coordinated by four O atoms from two pipemidic acid ligands in equatorial positions and two water mol-ecules in axial positions. The pipemidic acid ligand acts a bidentate ligand and the single deprotonated 4,4'-oxydibenzoic acid acts as an anion. Classical N-H?O and O-H?O hydrogen bonds are present in the crystal structure.

| S-EPMC3052055 | biostudies-literature

Diaqua-(5-carb-oxy-benzene-1,3-dicarboxyl-ato-?O(1))[8-ethyl-5-oxo-2-(piperazin-4-ium-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ato-?(2)O(5),O(6)]zinc monohydrate.

Project description:In the title compound, [Zn(C(14)H(17)N(5)O(3))(C(9)H(4)O(6))(H(2)O)(2)]·H(2)O, the complex mol-ecule exists in a zwitterionic form. The Zn(II) ion exhibits a distorted tetra-gonal-pyramidal geometry, being coordinated by two O atoms from the zwitterionic 8-ethyl-5-oxo-2-(piperazin-4-ium-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxyl-ate (L) ligand, one O atom from the 5-carb-oxy-benzene-1,3-dicarboxyl-ate dianion, [Hbtc](2-), and two O atoms from two aqua ligands. In the crystal, N-H?O and O-H?O hydrogen bonds link the components into a three-dimensional structure. The crystal packing exhibits ?-? inter-actions between the aromatic rings, with centroid-centroid distances in the range 3.466?(3)-3.667?(3)?Å.

| S-EPMC3569215 | biostudies-literature

Bis[8-ethyl-5-oxo-2-(piperazin-4-ium-1-yl)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carb-oxy-lic acid] 2,5-dicarb-oxy-benzene-1,4-di-carboxyl-ate octa-hydrate.

Project description:The asymmetric unit of the title compound, 2C(14)H(18)N(5)O(3) (+)·C(10)H(5)O(8) (2-)·8H(2)O, contains one [H(2)ppa](+)cation, one half of an [H(2)btec](2-) anion (H(4)btec = 1,2,4,5-benzene-tetra-carb-oxy-lic acid and Hppa = 8-ethyl-5-oxo-2-piperazin-1-yl-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carb-oxy-lic acid) that is completed by inversion symmetry and four water mol-ecules. In the crystal, the mol-ecules are connected by inter-molecular hydrogen-bonding inter-actions and π-π stacking between the benzene rings of the [H(2)btec](2-) anion and the pyrimidine rings of the [H(2)ppa](+) cation [centroid-centroid distance = 3.597 (3) Å], generating a three-dimensional supra-molecular structure.

| S-EPMC3099930 | biostudies-literature

Bis(2-carboxybenzo-ato-?O)bis-[1-cyclo-propyl-6-fluoro-4-oxo-7-(piperazin-4-ium-1-yl)-1,4-dihydro-quinoline-3-carboxyl-ato-?O,O]manganese(II) dihydrate.

Project description:The title compound, [Mn(C(17)H(18)FN(3)O(3))(2)(C(8)H(5)O(4))(2)]·2H(2)O or [Mn(cfH)(2)(1,2-Hbdc)(2)]·2H(2)O (cfH = ciprofloxacin = 1-cyclo-propyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazin-yl)-3-quinoline carb-oxy-lic acid, 1,2-bdc = benzene-1,2-dicarboxyl-ate), has been prepared under hydro-thermal conditions. The Mn(2+) atom, located on an inversion centre, exhibits a distorted octa-hedral geometry, coordinated by four O atoms from two symmetry-related zwitterionic ciprofloxacin ligands in the equatorial positions and two O atoms of two 1,2-Hbdc ligands in the axial positions. The complex mol-ecules are linked into a two-dimensional network through N-H?O and OW-H?O hydrogen bonds. A strong intramolecular hydrogen bond between the carboxyl/carboxylate groups of the 1,2-Hbdc anion is also present. The layers are further extended through off-set aromatic ?-? stacking inter-actions of cfH groups [centroid-centroid distance of 3.657?(2)?Å] into the final three-dimensional supra-molecular arrays.

| S-EPMC3089319 | biostudies-literature

Aqua-bis[1-ethyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxyl-ato]zinc(II) dihydrate.

Project description:The title compound, [Zn(C(17)H(19)FN(3)O(3))(2)(H(2)O)]·2H(2)O or [Zn(pef)(2)(H(2)O)]·2H(2)O, where pef is 1-ethyl-6-fluoro-7-(4-methyl-piperazin-4-yl)-4-oxo-1,4-dihydro-quinoline-3-carb-oxyl-ate, was synthesized under hydro-thermal conditions. The Zn(II) atom exhibits a distorted ZnO(5) square-pyramidal geometry defined by two bidentate O,O-bonded pef anions in the basal plane and one water mol-ecule in the apical position. A network of O-H?O and O-H?N hydrogen bonds is formed between the Zn(II) complexes and the uncoordinated water mol-ecules.

| S-EPMC2960459 | biostudies-literature

Poly[[[(1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-quinoline-3-carboxyl-ato)manganese(II)]-μ(3)-4,4'-oxydibenzoato] monohydrate].

Project description:In the title compound, {[Mn(C(16)H(18)N(3)O(3))(C(14)H(8)O(5))]·H(2)O}(n), the unique Mn(II) ion is coordinated by two O atoms from a chelating 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-quinoline-3-carboxyl-ate ligand and three O atoms from three 4,4'-oxydibenzoate ligands, forming a distorted square-pyramidal coordination environment. In the crystal structure, centrosymmetric dinuclear manganese units are linked via 4,4'-oxydibenzoate ligands into one-dimensional chains; these chains are, in turn, connected via inter-molecular N-H⋯O and O-H⋯O hydrogen bonds to form a two-dimensional supra-molecular network. The O atom of the solvent water mol-ecule is disordered over two sites with equal occupancies; the attached H atoms are common to both sites.

| S-EPMC2914913 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data